by McKesson Ventures | Sep 29, 2020 | Portfolio News
Hims, a direct-to-consumer telehealth startup, is close to securing a deal to go public through a merger with special-purpose acquisition company Oaktree Acquisition Corporation, according to a September 25 report in Bloomberg. According to people familiar with the...
by McKesson Ventures | Jul 23, 2020 | Portfolio News
Once upon a time, Hims was just another men’s wellness company offering hair loss and ED treatments, mail-order supplements, and other health tools. But with the onset of the COVID-19 pandemic, the company accelerated its plans to launch virtual primary care and...
by McKesson Ventures | Jun 24, 2020 | Portfolio News
McKesson Ventures portfolio company Hims & Hers is one of the first 12 national companies signing on to a pledge to guarantee employee birth control coverage, whether or not they are required to do so by law. Currently, under the Affordable Care Act, most...
by McKesson Ventures | Jun 11, 2020 | Portfolio News
Although states and cities are starting to ease social distancing mandates, many people still feel more comfortable doing what they can to minimize the risk of catching the coronavirus. To accommodate this, many doctors are offering telemedicine services. But if your...
by McKesson Ventures | May 13, 2020 | Portfolio News
Less than a week ago, the FDA authorized a home-collected saliva test for COVID-19. Now that test is available through telehealth companies Hims & Hers and Vault Health. Hims & Hers has greatly expanded its telehealth offerings over the past few months to meet...
